STAT3-IN-11
CAS No. 2503096-50-0
STAT3-IN-11 ( —— )
产品货号. M35503 CAS No. 2503096-50-0
STAT3-IN-11 (7a)是一种STAT3 选择性抑制剂,可抑制 STAT3 pTyr705 位点的磷酸化。STAT3-IN-11 可抑制下游基因 (Survivin 和 Mcl-1) 的磷酸化,且不影响上游酪氨酸激酶 (Src and JAK2) 和 p-STAT1 的表达。STAT3-IN-11 可诱导癌细胞凋亡,有望用于 STAT3 抑制剂和抗肿瘤试剂的发现。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥1925 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称STAT3-IN-11
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述STAT3-IN-11 (7a)是一种STAT3 选择性抑制剂,可抑制 STAT3 pTyr705 位点的磷酸化。STAT3-IN-11 可抑制下游基因 (Survivin 和 Mcl-1) 的磷酸化,且不影响上游酪氨酸激酶 (Src and JAK2) 和 p-STAT1 的表达。STAT3-IN-11 可诱导癌细胞凋亡,有望用于 STAT3 抑制剂和抗肿瘤试剂的发现。
-
产品描述STAT3-IN-11 (7a) is a selective STAT3 inhibitor that inhibits the phosphorylation of STAT3 at site pTyr705. STAT3-IN-11 inhibits the phosphorylation of downstream genes (Survivin and Mcl-1) without affecting its upstream tyrosine kinases (Src and JAK2) levels and p-STAT1 expression. STAT3-IN-11 can induce cancer cell apoptosis, which is potential for the discovery of effective STAT3 inhibitors and antitumor agents against cancers.
-
体外实验STAT3-IN-11 (20 μM, 48 h) has 97.86% inhibitory effect on MDA-MB-231 cells.STAT3-IN-11 (0-30 μM, 48 h) inhibits several cancer cells with IC50 values of 6.01 μM (MDA-MB-231), 7.02μM (HepG2, A549), and normal human cells with IC50 values of 26.54 μM (MDA-MB-10A), 26.69 μM (PBMCs), 12.52 μM (HFL-1) .STAT3-IN-11 (2.5-10 μM, 6 h) inhibits the phosphorylation of STAT3 (stimulated by IL-6 in MDA-MB-231) at site pTyr705 in a dose-dependent manner.STAT3-IN-11 (2.5-10 μM, 6 h) inhibits the expression of the downstream gene (Survivin and Mcl-1) of STAT3 in a concentration-dependent manner.STAT3-IN-11 (2.5-10 μM, 6 h) has no effects on the typical upstream kinases of STAT3 such as p-JAK2 and p-Src and the phosphorylation of STAT1 (a STAT isoform) .STAT3-IN-11 (2.5-10 μM, 48 h) can induce cell apoptosis in a dose-manner.Cell Cytotoxicity Assay Cell Line:MDA-MB-231 cells Concentration:20 μM Incubation Time:48 hours Result:The antiproliferative activity reached 97.86%.Cell Cytotoxicity Assay Cell Line:MDA-MB231, A549, MDA-MB-10A, PBMCs and HFL-1 cells Concentration:20 μM Incubation Time:48 hours Result:Inhibited with IC50 values of 6.01, 7.20, 7.02, 26.54, 25.69 and 12.52 μM for MDA-MB231, A549, MDA-MB-10A, PBMCs and HFL-1 cells, respectively.Western Blot Analysis Cell Line:MDA-MB-231 cells Concentration:2.5,5 and 10 μM Incubation Time:6 hours Result:Decrease the level of p-STAT3 at site pTyr705 in a concentration dependent manner.Western Blot Analysis Cell Line:MDA-MB-231 cells Concentration:2.5,5 and 10 μM Incubation Time:6 hours Result:Down-regulated the level of STAT3 downstream genes.Apoptosis Analysis Cell Line:MDA-MB-231 cells Concentration:5, 10 and 15 μM Incubation Time:48 hours Result:The percentage of apoptotic cells was 24.4% at a concentration of 15 μM.
-
体内实验——
-
同义词——
-
通路Apoptosis
-
靶点Apoptosis
-
受体Apoptosis | STAT
-
研究领域——
-
适应症——
化学信息
-
CAS Number2503096-50-0
-
分子量335.35
-
分子式C20H17NO4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 100 mg/mL (298.20 mM; 超声助溶 )
-
SMILESCC1=C(CCNC(=O)c2ccccc2)C(=O)c2c(O)cccc2C1=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Li N, et al. Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition. Bioorg Chem. 2020 Nov;104:104208. ?
产品手册
关联产品
-
CNX-774
CNX-774 是一种高度特异性、不可逆、口服活性的 BTK 抑制剂 (IC50<1 nM)。
-
Hematoporphyrin mono...
Hematoporphyrin monomethyl ether 是第二代卟啉类光敏剂,具有形态单一、单线态氧产率高、选择性高、毒性低等特点,广泛应用于各种肿瘤的诊断和研究,包括肺癌、膀胱癌,脑胶质瘤与焰色痣。
-
Rigosertib
Rigosertib 是一种选择性、非 ATP 竞争性 PLK1 抑制剂 (IC50: 9 nM)。
021-51111890
购物车()
sales@molnova.cn

